QLINEA Q-linea AB (publ)
17.00SEK-0.29%Mkt Cap: 30.81M $P/E: —1d ago
Q-linea AB (publ) engages in the manufacturing and sale of instruments and consumables diagnose and treat infectious diseases in the United Kingdom, the United States, France, the Middle East, Belgium, Italy, and Finland…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap30.81M USD
Enterprise Value14.15M USD
Revenue (TTM)1.38M USD
Gross Profit-161.94K USD
Net Income (TTM)-17.46M USD
Revenue/Share2.17 SEK
Last Price17.00 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees70
CountrySE
SectorHealthcare
IndustryMedical Devices
ISINSE0011527845
Valuation
P/E (Trailing)—
P/E (Forward)-56.83
PEG—
EV/EBITDA-1.07
EV/Revenue10.24
P/S22.36
P/B1.18
EPS (TTM)-13.20
EPS (Forward)-0.30
52W Range
14.5510% of range38.42
52W High38.42 SEK
52W Low14.55 SEK
Profitability
Gross Margin-15.26%
Oper. Margin-820.16%
EBITDA Margin0.00%
Profit Margin-1644.31%
ROE-53.99%
ROA-49.36%
Growth
Revenue Growth209.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-15.51M USD
CapEx (TTM)723.23K USD
FCF Margin-821.24%
FCF Yield-36.83%
Net Debt-16.75M USD
Net Debt/EBITDA1.27
Balance Sheet
Debt/Equity0.02
Current Ratio117.99
Quick Ratio85.48
Book Value/Sh14.50 SEK
Cash/Share9.86 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 SEK
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:1000
Split DateJul 14, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.18.95M
Float11.64M
Insiders12.89%
Institutions27.37%
Technical
SMA 5018.18 (-6.5%)
SMA 20020.57 (-17.4%)
Beta0.59
S&P 52W Chg14.58%
Avg Vol (30d)5.93K
Avg Vol (10d)8.36K
Technical Indicators
RSI (14)35.2
MACD-0.2932
MACD Signal-0.1631
MACD Hist.-0.1301
BB Upper19.01 SEK
BB Middle17.97 SEK
BB Lower16.92 SEK
BB Width11.63%
ATR (14)0.6057 SEK
Vol Ratio (20d)0.54x